Blood pressure reduction in the morning yields beneficial effects on progression of chronic renal insufficiency with regression of left ventricular hypertrophy

Clinical and Experimental Hypertension

Volumn 24, Issue 1-2, 2002, Pages 51-63

  Suzuki, H ^a   Moriwaki, K ^a   Nakamoto, H ^a   Sugahara, S ^a   Kanno, Y ^a   Okada, H ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Amlodipine; Benazepril; Guanabenz; Self reported blood pressure measurement

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; BENAZEPRIL; GUANABENZ; PLACEBO;

ADULT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SELF MONITORING; SINGLE BLIND PROCEDURE;

ADRENERGIC ALPHA-AGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CIRCADIAN RHYTHM; CREATININE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; GUANABENZ; HOME CARE SERVICES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OFFICE VISITS; PROTEINURIA;

EID: 0036166249     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100108715     Document Type: Conference Paper

References (42)

1. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
2. Left ventricular hypertrophy in renal failure
3. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy
4. Current approaches in the treatment of hypertension
5. Ambulatory blood pressure monitoring and echocardiography-noninvasive techniques for evaluation of the hypertensive patient
6. Ambulatory blood pressure monitoring is a useful clinical tool in nephrology
7. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy
8. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening
9. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy
10. Home blood pressure monitoring
11. Reference values for self-recorded blood pressure
12. Electrocardiogram in evaluation of resistance to antihypertensive therapy
13. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure
14. Sympathetic overactivity and 24-hour blood pressure pattern in hypertensives with chronic renal failure
15. Changes of nocturnal blood pressure dipping status in hypertensive by nighttime dosing of α-adrenergic blocker, doxazosin. Results from the halt study
16. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass
17. Effect of amlodipine on morbidity and mortality in severe congestive heart failure
18. Effect of the angiotensin convertingenzyme inhibitor benazepril on the progression of chronic renal insufficiency
19. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine
20. Effect of benazepril plus amlodipine vs benazepril alone on urinary albumin excretion in hypertensive patients with type II diabetes and microalbuminuria
21. Studies on the centrally mediated hypotensive activity of guanabenz
22. Echocardiographic determination of left ventricular mass in man
23. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure
24. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension
25. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction; Results of the survival and ventricular enlargement trial
26. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia
27. The Influence of ACE-Inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure
28. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure
29. Comobidity of hypertension and diabetes: The fosionpril versus amlodipine in cardiovascular events trial
30. Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure
31. Not all left ventricular hypertrophy is created equal
32. Labetalol blunts morning pressor surge in systolic hypertension
33. The reproducibility of average ambulatory, home, and clinic pressures
34. Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal tranplantation
35. Ambulatory blood pressure monitoring assessment of blood pressure control in hypertension associated with chronic renal failure
36. Circadian blood pressure variation versus renal function
37. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications
38. Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central α1-adrenoceptor agonist guanabenz in rats with aortic constriction
39. Time course of regression of left ventricular hypertrophy in treated hypertensive patients
40. Guanabenz combination therapy inhibits sympathetic nerve activity and regresses left ventricular hypertrophy
41. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
42. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease